The argument for pharmaceutical policy

被引:9
|
作者
Traulsen, JM
Almarsdóttir, AB
机构
[1] Danish Univ Pharmaceut Sci, Dept Social Pharm, DK-2100 Copenhagen O, Denmark
[2] Univ Iceland, Fac Pharm, Reykjavik, Iceland
[3] AL BAS Pharmaceut Consultants Ltd, Reykjavik, Iceland
来源
PHARMACY WORLD & SCIENCE | 2005年 / 27卷 / 01期
关键词
health care; pharmaceutical policy; pharmacy administration;
D O I
10.1007/s11096-004-5151-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Pharmaceutical policy is a global concern. It has become a hot political topic in most countries - developed as well as developing - and can be found on the agenda of international organizations such as WHO, OECD, EU, WTO and even the World Bank. Pharmaceutical policy affects everyone in the world of pharmacy and it is therefore imperative that it be understood, discussed and debated within the pharmacy profession and included in the curriculum of schools of pharmacy. This, the first article in a series, argues for the importance of the academic discipline of pharmaceutical policy analysis and the involvement of pharmacists in this endeavour. The aim of the authors is to stimulate an informed and critical appreciation of this field. The authors begin with an introduction to the field of pharmaceutical policy, introducing several important concepts and current trends including: medicines regulation; how pharmaceutical policy is made; pharmaceutical policy as a dynamic process; and the new public health as a global issue. The article ends with a short description of the remaining five articles in the series which will deal with important aspects of pharmaceutical policy. The topics include: economic pressures on health care systems; drug utilization from the clinical viewpoint ( rational use of medicines); the impact of pharmaceutical policy on patients and the patient impact on pharmaceutical policy; the professional perspective; and finally the last article which deals with studying and evaluating pharmaceutical policy.
引用
收藏
页码:7 / 12
页数:6
相关论文
共 50 条
  • [41] A pharmaceutical policy accident: collision of shareholder capitalism and Chinese state capitalism driving the shortage of an essential antibiotic
    Wells, Nadya
    Nguyen, Vinh-Kim
    Harbarth, Stephan
    JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2024, 17 (01)
  • [42] Sex, drugs and gender roles: mapping the use of sex and gender based analysis in pharmaceutical policy research
    Devon L Greyson
    Annelies RE Becu
    Steven G Morgan
    International Journal for Equity in Health, 9
  • [43] The Belgian commitment to pharmaceutical quality: a model policy to improve quality assurance of medicines available through humanitarian and development programs
    Ravinetto, Raffaella
    Roosen, Tim
    Dujardin, Catherine
    JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2018, 11 (01)
  • [44] The Belgian commitment to pharmaceutical quality: a model policy to improve quality assurance of medicines available through humanitarian and development programs
    Raffaella Ravinetto
    Tim Roosen
    Catherine Dujardin
    Journal of Pharmaceutical Policy and Practice, 11 (1)
  • [45] Comparison of pharmaceutical policies to stimulate use of generics in Japan and Sweden
    Imai, Shinobu
    Sundell, Karolina Andersson
    Fushimi, Kiyohide
    HEALTH POLICY AND TECHNOLOGY, 2016, 5 (02) : 189 - 195
  • [46] Performance of a pharmaceutical services regionalization strategy policy in Minas Gerais, Brazil: Pre-post analysis from ERAF project
    Luz, Tatiana Chama Borges
    de Castro, Ana Karine Sarvel
    Marques, Isabela Cristina
    Cota, Betania Barros
    Alves, Jessica de Castro
    Law, Michael Robert
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [47] Telepharmacy and pharmaceutical care: A narrative review by International Pharmaceutical Federation
    Viegas, Ruben
    Dineen-Griffin, Sarah
    Soderlund, Lars-Ake
    Acosta-Gomez, Jaime
    Guiu, Josep Maria
    FARMACIA HOSPITALARIA, 2022, 46 : 86 - 91
  • [48] Economics of the Pharmaceutical Industry
    Lakdawalla, Darius N.
    JOURNAL OF ECONOMIC LITERATURE, 2018, 56 (02) : 397 - 449
  • [49] A Pragmatist Argument for Mixed Methodology in Medical Informatics
    Scott, Philip J.
    Briggs, James S.
    JOURNAL OF MIXED METHODS RESEARCH, 2009, 3 (03) : 223 - 241
  • [50] Reducing patient copayment levels for topical and systemic treatments in plaque psoriasis as a case for evidence-based, sustainable pharmaceutical policy change in Greece
    Souliotis, Kyriakos
    Golna, Christina
    Kani, Chara
    Litsa, Panagiota
    JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (11) : 1021 - 1026